Kellina Maduray
Overview
Explore the profile of Kellina Maduray including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maduray K, Zhong J
Am J Physiol Cell Physiol
. 2024 Oct;
327(6):C1416-C1432.
PMID: 39401423
Cardiac fibrosis, characterized by excessive extracellular matrix (ECM) deposition within the myocardium, poses a significant challenge in cardiovascular health, contributing to various cardiac pathologies. Ketone bodies (KBs), particularly β-hydroxybutyrate (β-OHB),...
2.
Hu T, Chen T, Maduray K, Han W, Zhong J
Rev Cardiovasc Med
. 2024 Jul;
25(6):191.
PMID: 39076314
Researchers have investigated ways to develop optimal imaging techniques to increase the safety and effectiveness of electrophysiological (EP) procedures. Intracardiac echocardiography (ICE) is an advanced imaging tool that can directly...
3.
Hu T, Chen C, Maduray K, Han W, Chen T, Zhong J
Thromb J
. 2024 Mar;
22(1):23.
PMID: 38429631
Background And Objective: Left ventricular thrombus (LVT) formation in patients with acute myocardial infarction (AMI) or cardiomyopathies is not uncommon. The optimal oral anticoagulation therapy for resolving LVT has been...
4.
Han W, Wang W, Wang Q, Maduray K, Hao L, Zhong J
Front Pharmacol
. 2024 Feb;
15:1267585.
PMID: 38414735
Myocardial infarction (MI) imposes a huge medical and economic burden on society, and cardiac repair after MI involves a complex series of processes. Understanding the key mechanisms (such as apoptosis,...
5.
Hu T, Li Y, Han W, Maduray K, Chen T, Hao L, et al.
Am J Cardiovasc Drugs
. 2023 Aug;
23(6):683-694.
PMID: 37639201
Background: Prevention of ischemic stroke is an essential part of managing atrial fibrillation (AF). In recent years, direct oral anticoagulants (DOACs) have emerged as an alternative to vitamin K antagonists...
6.
Chen T, Chang L, Rong B, Zhang K, Fan G, Kong J, et al.
J Clin Med
. 2023 May;
12(9).
PMID: 37176594
Objectives: The catheter ablation of ventricular arrhythmias (VAs) arising from the left ventricular (LV) papillary muscles (PMs) is challenging. This study sought to address whether the combination of intracardiac echocardiography...
7.
Liu H, Lin M, Han W, Ge J, Maduray K, Zhong J
BMC Cardiovasc Disord
. 2023 Jan;
23(1):28.
PMID: 36650447
Background: Atrial fibrillation (AF) predisposes patients to the formation of atrial thrombi. The CHADS-VASc score does not include all risk factors for atrial thrombosis. The present study is designed to...
8.
Ge J, Han W, Ma C, Maduray K, Chen T, Zhong J
Clin Appl Thromb Hemost
. 2022 Dec;
28:10760296221145168.
PMID: 36524251
Novel oral anticoagulants (NOACs) are preferentially recommended in patients with nonvalvular atrial fibrillation (AF) for stroke prevention over vitamin K antagonists (VKAs). However, the evidence regarding the efficacy and safety...
9.
Ge J, Han W, Ma C, Chen T, Liu H, Maduray K, et al.
Front Cardiovasc Med
. 2022 Nov;
9:1027000.
PMID: 36426220
Background: Acetaldehyde dehydrogenase 2 (ALDH2) is an essential enzyme in alcohol metabolism, playing a vital function in resisting oxidative stress. Lots of gene variants have been associated with atrial fibrillation...
10.
Han W, Liu Y, Sha R, Liu H, Liu A, Maduray K, et al.
Front Cardiovasc Med
. 2022 Sep;
9:934664.
PMID: 36158848
Background: At present, catheter ablation is an effective method for rhythm control in patients with atrial fibrillation (AF). However, AF recurrence is an inevitable problem after catheter ablation. To identify...